mTORC-1 Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2014468)
◆英語タイトル:mTORC-1 Inhibitors -Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2014468
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[mTORC-1 Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“mTORC-1 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under mTORC-1 Inhibitors. This report provides information on the therapeutic development based on the mTORC-1 Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of mTORC-1 Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the mTORC-1 Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for mTORC-1 Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

• Complete MOA intelligence and complete understanding over therapeutics development for mTORC-1 Inhibitors
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding mTORC-1 Inhibitors pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

*** レポート目次(コンテンツ)***

• mTORC-1 Inhibitors Overview
• mTORC-1 Inhibitors Disease Associated
• mTORC-1 Inhibitors Pipeline Therapeutics
• mTORC-1 Inhibitors Therapeutics under Development by Companies
• mTORC-1 Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• mTORC-1 Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• mTORC-1 Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• mTORC-1 Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• mTORC-1 Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• mTORC-1 Inhibitors – Discontinued Products
• mTORC-1 Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for mTORC-1 Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for mTORC-1 Inhibitors by Therapy Area, 2014
• Number of Products under Development for mTORC-1 Inhibitors, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• mTORC-1 Inhibitors Assessment by Monotherapy Products
• mTORC-1 Inhibitors Assessment by Combination Products
• mTORC-1 Inhibitors Assessment by Route of Administration
• mTORC-1 Inhibitors Assessment by Stage and Route of Administration
• mTORC-1 Inhibitors Assessment by Molecule Type
• mTORC-1 Inhibitors Assessment by Stage and Molecule Type
• mTORC-1 Inhibitors Therapeutics – Discontinued Products
• mTORC-1 Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2014

• Number of Products under Development for mTORC-1 Inhibitors by Therapy Area, 2014
• Number of Products under Development for mTORC-1 Inhibitors, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• mTORC-1 Inhibitors Assessment by Monotherapy Products
• mTORC-1 Inhibitors Assessment by Combination Products
• mTORC-1 Inhibitors Assessment by Route of Administration
• mTORC-1 Inhibitors Assessment by Stage and Route of Administration
• mTORC-1 Inhibitors Assessment by Molecule Type
• mTORC-1 Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • p-クロロベンジルアミンの世界市場:販売動向2017
    Notes:Sales, means the sales volume of p-Chlorobenzylamine Revenue, means the sales value of p-Chlorobenzylamine This report studies sales (consumption) of p-Chlorobenzylamine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, w …
  • 世界及び中国のウォッシュガードデューティDCモータ市場2017
    The 'Global and Chinese Washguard Duty DC Motor Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Washguard Duty DC Motor industry with a focus on the Chinese market. The report provides key statistics on the market status of the Wash …
  • インスリン抵抗性(Insulin Resistance):治療薬パイプラインレビュー
    Insulin Resistance - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Insulin Resistance - Pipeline Review, H2 2018, provides an overview of the Insulin Resistance (Metabolic Disorders) pipeline landscape. Insulin resistance (IR) is …
  • 世界の発電所ボイラー市場2016
    The Global Power Station Boiler Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Power Station Boiler industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain s …
  • 世界の天然ガス船舶推進エンジン市場2017
    Natural Gas Marine Propulsion Engine Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries ( …
  • 世界のX線装置(医療機器)市場2014:主要企業の戦略的分析
    This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs. The report includes information [u]not available from any other …
  • Dementia:治療薬開発パイプライン動向(2014年上半期、グローバル製薬市場)
    Dementia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dementia - Pipeline Review, H1 2014’, provides an overview of the Dementia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at v …
  • シンソンFA(SHINSUNG FA CO., LTD.)企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 中国のエタノールアミン市場予測(生産、需要、市場規模)
    This study focuses on China’s Ethanolamines industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the …
  • 工業用振動センサの世界市場見通し2017-2026
    According to Stratistics MRC, the Global Industrial Vibration Sensor market is expected to grow at a CAGR of 13.21% by 2026. The growth of the market is propelled by rising reputation of smart factories which drive the need for sensing technologies, increasing demand for collaborative robots and gro …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2014468 )"mTORC-1 Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)" (英文:mTORC-1 Inhibitors -Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。